These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22613561)

  • 1. The uncoupling protein 2 -866G > a polymorphism is associated with the risk of ischemic stroke in Chinese type 2 diabetic patients.
    Chai Y; Gu B; Qiu JR; Yi HG; Zhu Q; Zhang L; Hu G
    CNS Neurosci Ther; 2012 Aug; 18(8):636-40. PubMed ID: 22613561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of uncoupling protein 2 -866G/A polymorphism on platelet reactivity and prognosis in Chinese patients with type 2 diabetes and ischemic stroke.
    Chai Y; Gu B; Qiu JR; Yi HG; Zhu Q; Zhang L; Hu G
    Int J Neurosci; 2013 Nov; 123(11):752-8. PubMed ID: 23621569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
    Cheurfa N; Dubois-Laforgue D; Ferrarezi DA; Reis AF; Brenner GM; Bouché C; Le Feuvre C; Fumeron F; Timsit J; Marre M; Velho G
    Diabetes; 2008 Apr; 57(4):1063-8. PubMed ID: 18192542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of functional UCP2 -866G/A and Ala55Val polymorphisms and type 2 diabetes in the Chinese population based on a case-control study and a meta-analysis.
    Qin LJ; Wen J; Qu YL; Huang QY
    Genet Mol Res; 2013 Sep; 12(3):3324-34. PubMed ID: 24065674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: case-control study and meta-analysis.
    de Souza BM; Brondani LA; Bouças AP; Sortica DA; Kramer CK; Canani LH; Leitão CB; Crispim D
    PLoS One; 2013; 8(1):e54259. PubMed ID: 23365654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study.
    Xu K; Zhang M; Cui D; Fu Y; Qian L; Gu R; Wang M; Shen C; Yu R; Yang T
    Diabetologia; 2011 Sep; 54(9):2315-24. PubMed ID: 21751002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients.
    Phulukdaree A; Moodley D; Khan S; Chuturgoon AA
    Gene; 2013 Jul; 524(2):79-83. PubMed ID: 23639961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling protein 2 and 3 gene polymorphisms and their association with type 2 diabetes in asian indians.
    Vimaleswaran KS; Radha V; Ghosh S; Majumder PP; Sathyanarayana Rao MR; Mohan V
    Diabetes Technol Ther; 2011 Jan; 13(1):19-25. PubMed ID: 21175267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.
    Yamasaki H; Sasaki H; Ogawa K; Shono T; Tamura S; Doi A; Sasahara M; Kawashima H; Nakao T; Furuta H; Nishi M; Nanjo K
    Diabetes Care; 2006 Apr; 29(4):888-94. PubMed ID: 16567833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus.
    Crispim D; Fagundes NJ; dos Santos KG; Rheinheimer J; Bouças AP; de Souza BM; Macedo GS; Leiria LB; Gross JL; Canani LH
    Clin Endocrinol (Oxf); 2010 May; 72(5):612-9. PubMed ID: 19681913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
    Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
    Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and metabolic syndrome in Asians.
    Shen H; Qi L; Tai ES; Chew SK; Tan CE; Ordovas JM
    Obesity (Silver Spring); 2006 Apr; 14(4):656-61. PubMed ID: 16741267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCP2 -866G/A, Ala55Val and UCP3 -55C/T polymorphisms in association with obesity susceptibility - a meta-analysis study.
    Qian L; Xu K; Xu X; Gu R; Liu X; Shan S; Yang T
    PLoS One; 2013; 8(4):e58939. PubMed ID: 23560041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction.
    Palmer BR; Devereaux CL; Dhamrait SS; Mocatta TJ; Pilbrow AP; Frampton CM; Skelton L; Yandle TG; Winterbourn CC; Richards AM; Montgomery HE; Cameron VA
    Cardiovasc Diabetol; 2009 Jun; 8():31. PubMed ID: 19527523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of variants in UCP2 in Chinese type 2 diabetes and diabetic retinopathy.
    Shen Y; Wen Z; Wang N; Zheng Z; Liu K; Xia X; Gu Q; Shi Y; Xu X
    PLoS One; 2014; 9(11):e112670. PubMed ID: 25396419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.